Home / BDKRB2 Knockout Cell Lines

BDKRB2 Knockout Cell Lines

Gene: BDKRB2

Official Full Name: bradykinin receptor B2provided by HGNC

Gene Summary: This gene encodes a receptor for bradykinin. The 9 aa bradykinin peptide elicits many responses including vasodilation, edema, smooth muscle spasm and pain fiber stimulation. Bradykinin is released upon activation by pathophysiologic conditions such as trauma and inflammation, and binds to its kinin receptors, B1 and B2. The B2 receptor associates with G proteins that stimulate a phosphatidylinositol-calcium second messenger system. [provided by RefSeq, Apr 2020]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO08066 BDKRB2 Knockout cell line (HeLa) Human BDKRB2 1:3~1:6 Negative Online Inquiry
KO08067 BDKRB2 Knockout cell line (A549) Human BDKRB2 1:3~1:4 Negative Online Inquiry

Background

BDKRB2 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to facilitate the study of the BDKRB2 gene, which encodes the bradykinin B2 receptor. This receptor plays a pivotal role in various physiological processes, including inflammation, pain sensation, and vascular regulation. By creating knockout models, researchers can effectively eliminate the expression of the BDKRB2 gene, enabling them to investigate its functions and the resulting phenotypic changes in cellular behavior.

The key mechanism of action involves CRISPR/Cas9 technology, which allows for precise editing of the genome to produce the desired knockout effect. Researchers can utilize these cell lines to delineate the signaling pathways initiated by the BDKRB2 receptor and explore its involvement in pathological states, such as cardiovascular diseases or chronic pain syndromes. This insight is critical for dissecting the underlying mechanisms associated with these conditions and may lead to the identification of novel therapeutic targets.

In scientific research and clinical settings, BDKRB2 Gene Knockout Cell Lines are invaluable tools for drug discovery and development. By using these models, researchers can evaluate the efficacy of potential pharmacological agents aimed at modulating the activity of the BDKRB2 receptor. Unlike alternative models that may not accurately replicate the specific genetic makeup or signaling context, these knockout cell lines provide a more precise and reliable platform for evaluating the biological responses to therapeutics.

The advantages of BDKRB2 Gene Knockout Cell Lines are substantial; they facilitate high-throughput screening, allow for detailed mechanistic studies, and promote a deeper understanding of the BDKRB2 receptor's role in various disease states. They are particularly beneficial for researchers and clinicians looking to develop targeted therapies that can mitigate adverse conditions related to altered bradykinin signaling.

Our company specializes in the development of innovative biological products tailored to meet the evolving demands of the research community. With a commitment to quality and scientific integrity, we provide robust tools like BDKRB2 Gene Knockout Cell Lines, empowering researchers to advance their studies in cellular and molecular biology.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.